Literature DB >> 25772380

Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.

Léon Tremblay1, Yulia Worbe2, Stéphane Thobois1,3,4, Véronique Sgambato-Faure1, Jean Féger2.   

Abstract

Historically, Parkinson's disease (PD) was defined as a pure movement disorder. Currently, it is widely accepted that this disease is also characterized by nonmotor signs, such as depression, apathy, and anxiety. On the other hand, the consideration of Gilles de la Tourette syndrome (GTS) as a neuropsychiatric disorder has also been debated. In this review, we will focus on these two disorders, which combine both motor and behavioral features and in which dysfunction of cortical and subcortical regions was suggested. Anatomical, experimental, and clinical data are reported to support the involvement of basal ganglia (BG) in cognitive and motivational functions in addition to motor control. In PD, the nonmotor signs could result from the heterogeneity of dopaminergic lesions and excessive activation of the dopamine receptors, particularly within the limbic neuronal networks. Experimental results obtained on nonhuman primates using local disinhibition within functional territories of BG allowed the precise mapping of their motor and nonmotor functions. Thus, impairment of inhibitory control inside specific striatal territories induced behavioral disorders and abnormal movements, which had striking similarities to clinical expressions of GTS. Establishing such a relationship between BG subterritories and motor and behavioral disorders could potentially be helpful for future target choices for DBS in many neuropsychiatric disorders. Furthermore, it is also of great interest for therapeutic research and for the efficient targeting of symptom relief to determine the precise pharmacological effects of the two main modulators of BG function, which are dopamine and serotonin.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  GABA inhibition; MPTP; Parkinson's disease; Tourette's syndrome; basal ganglia; deep brain stimulation; dopamine; dopamine dysregulation syndrome; dyskinesia; fast spiking interneurons; impulse control disorders; nonhuman primate; pallidum; serotonin; striatum

Mesh:

Year:  2015        PMID: 25772380     DOI: 10.1002/mds.26199

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  52 in total

1.  Why so many deep brain stimulation targets in Tourette's syndrome? Toward a broadening of the definition of the syndrome.

Authors:  Mauro Porta; Christian Saleh; Edvin Zekaj; Carlotta Zanaboni Dina; Alberto R Bona; Domenico Servello
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

Review 2.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

3.  Computerized assessment of goal-directed behavior in Parkinson's disease.

Authors:  Whitney Fitts; Lauren Massimo; Nicholas Lim; Murray Grossman; Nabila Dahodwala
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

4.  Disinhibition of the Nucleus Accumbens Leads to Macro-Scale Hyperactivity Consisting of Micro-Scale Behavioral Segments Encoded by Striatal Activity.

Authors:  Dorin Yael; Orel Tahary; Boris Gurovich; Katya Belelovsky; Izhar Bar-Gad
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

5.  HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific.

Authors:  Douglas R Miller; Fatemeh Shaerzadeh; Leah Phan; Nesrin Sharif; Joyonna Gamble-George; Jay P McLaughlin; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  Glia       Date:  2018-05-07       Impact factor: 7.452

6.  Non-motor symptoms of Parkinson's disease: dopaminergic basis or not?

Authors:  Chanwoo Kim
Journal:  Neurol Sci       Date:  2019-06-17       Impact factor: 3.307

7.  Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications.

Authors:  Gina Ferrazzano; Isabella Berardelli; Antonella Conte; Viola Baione; Cristina Concolato; Daniele Belvisi; Giovanni Fabbrini; Giovanni Defazio; Alfredo Berardelli
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

Review 8.  Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers.

Authors:  Véronique Sgambato; Léon Tremblay
Journal:  J Neural Transm (Vienna)       Date:  2018-03-03       Impact factor: 3.575

Review 9.  Two different mirror neuron networks: The sensorimotor (hand) and limbic (face) pathways.

Authors:  P F Ferrari; M Gerbella; G Coudé; S Rozzi
Journal:  Neuroscience       Date:  2017-07-04       Impact factor: 3.590

10.  EEG marker of inhibitory brain activity correlates with resting-state cerebral blood flow in the reward system in major depression.

Authors:  A Cantisani; T Koenig; K Stegmayer; A Federspiel; H Horn; T J Müller; R Wiest; W Strik; S Walther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-21       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.